Literature DB >> 33326104

Metastasis Assessment in Ewing Sarcoma Using Orthotopic Xenografts.

Roser López-Alemany1, Oscar M Tirado2,3.   

Abstract

Orthotopic models are based on the implantation of tumor cells directly into the organ of origin, which allows interaction between the cells and the surrounding host tissues.Here we describe a modified version of an orthotopic model that closely recapitulates the steps required for metastasis development in Ewing sarcoma: tumor cells are injected into the calf muscles of the mouse, and once the tumor reaches a certain volume, the muscles containing the tumor are surgically resected. This procedure involves a nonaggressive surgery of the muscle which allows for the survival of the mouse during a period of time that is long enough to enable the development of distant metastases. This spreading of tumor cells to metastatic sites in other organs takes place by a physiological mechanism similar to what occurs in human Ewing sarcoma.

Entities:  

Keywords:  Ewing sarcoma; Metastasis detection; Mouse surgery; Orthotopic model; Xenograft model

Mesh:

Year:  2021        PMID: 33326104     DOI: 10.1007/978-1-0716-1020-6_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  A Visualized Dynamic Prediction Model for Lymphatic Metastasis in Ewing's Sarcoma for Smart Medical Services.

Authors:  Wenle Li; Chan Xu; Zhaohui Hu; Shengtao Dong; Haosheng Wang; Qiang Liu; Zhi-Ri Tang; Wanying Li; Bing Wang; Zhi Lei; Chengliang Yin
Journal:  Front Public Health       Date:  2022-05-04

2.  Establishment and Characterisation of Metastatic Extraskeletal Ewing Sarcoma Mouse Models.

Authors:  Carmelo Cerra; Michael A Harris; Christine J Hawkins
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

3.  Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1.

Authors:  Enrique de Álava; Lourdes Hontecillas-Prieto; Daniel J García-Domínguez; Nabil Hajji; Roser López-Alemany; Sara Sánchez-Molina; Elisabet Figuerola-Bou; Francisco J Morón Civanto; Santiago Rello-Varona; Eduardo Andrés-León; Adrián Benito; Hector C Keun; Jaume Mora; Óscar M Tirado
Journal:  Oncogene       Date:  2022-03-30       Impact factor: 8.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.